Management of neuropsychiatric lupus

Best Practice and Research: Clinical Rheumatology

Volumn 19, Issue 5 SPEC. ISS., 2005, Pages 799-821

  Hanly, John G ^a   Harrison, Melanie J ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Autoantibodies; Cognitive function; Lupus; Nervous system; Neuropsychiatric; treatment

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTITHROMBOCYTIC AGENT; ANXIOLYTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; BIOLOGICAL MARKER; CD20 ANTIBODY; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUROLEPTIC AGENT; PHOSPHOLIPID ANTIBODY; PREDNISONE; WARFARIN;

ANXIETY; BRAIN SCINTISCANNING; CEREBROVASCULAR DISEASE; CHOREA; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CYTOKINE RELEASE; DEMYELINATION; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG PULSE THERAPY; HEADACHE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; MAGNETIC RESONANCE ANGIOGRAPHY; MENTAL DISEASE; MOOD DISORDER; MYASTHENIA GRAVIS; NERVOUS SYSTEM FUNCTION; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTHERAPY; REVIEW; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME; UREMIA; VASCULAR DISEASE;

EID: 24344477115     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2005.04.003     Document Type: Review

References (152)

1. J.G. Hanly Evaluation of patients with CNS involvement in SLE Baillieres Clinical Rheumatology 12 3 1998 415-431
2. A. How et al. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus Arthritis and Rheumatism 28 7 1985 789-795
3. S.G. West Neuropsychiatric lupus Rheumatic Diseases Clinics of North America 20 1 1994 129-158
4. American College of Rheumatology (ACR) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes Arthritis and Rheumatism 42 4 1999 599-608
5. H. Ainiala et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: A population-based evaluation Arthritis and Rheumatism 45 5 2001 419-423
6. R.L. Brey et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions Neurology 58 8 2002 1214-1220
7. J.G. Hanly G. McCurdy L. Fougere et al. Neuropsychiatric events in systemic lupus erythematosus: Attribution and clinical significance Journal of Rheumatology 31 11 2004 2156-2162
8. G. Sanna et al. Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies Journal of Rheumatology 30 5 2003 985-992
9. W.L. Sibbitt Jr et al.The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus Journal of Rheumatology 29 7 2002 1536-1542
10. J.G. Hanly N.M. Walsh V. Sangalang Brain pathology in systemic lupus erythematosus Journal of Rheumatology 19 5 1992 732-741
11. R.T. Johnson E.P. Richardson The neurological manifestations of systemic lupus erythematosus Medicine (Baltimore) 47 4 1968 337-369
12. O. Devinsky C.K. Petito D.R. Alonso Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura Annals of Neurology 23 4 1988 380-384
13. S.G. Ellis M.A. Verity Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955-1977 Seminars in Arthritis and Rheumatism 8 3 1979 212-221
14. S.M. Weiner R. Klein P.A. Berg A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases Rheumatology International 19 3 2000 83-88
15. H.G. Bluestein G.W. Williams A.D. Steinberg Cerebrospinal fluid antibodies to neuronal cells: Association with neuropsychiatric manifestations of systemic lupus erythematosus American Journal of Medicine 70 2 1981 240-246
16. N.J. Zvaifler H.G. Bluestein The pathogenesis of central nervous system manifestations of systemic lupus erythematosus Arthritis and Rheumatism 25 7 1982 862-866
17. E. Martinez-Cordero B.E. Rivera Garcia D.E. Aguilar Leon Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus Journal of Investigation Allergological and Clinical Immunology 7 6 1997 596-601
18. N.J. Abbott L.L. Mendonca D.E. Dolman The blood-brain barrier in systemic lupus erythematosus Lupus 12 12 2003 908-915
19. J.M. Prins J.W. de Glas-Vos [Cerebral disseminated lupus erythematosus; brain-racking for patient and physician] Nederlands Tijdschrift voor Geneeskunde 134 46 1990 2252-2256
20. S. Ozawa H. Kamiya K. Tsuzuki Glutamate receptors in the mammalian central nervous system Progress in Neurobiology 54 5 1998 581-618
21. C.R. Scherzer et al. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: Hippocampus and cortex The Journal of Comparative Neurology 390 1 1998 75-90
22. R.G. Morris et al. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 Nature 319 6056 1986 774-776
23. S. Akbarian et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics Journal of Neuroscience 16 1 1996 19-30
24. J.D. Jentsch R.H. Roth The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 3 1999 201-225
25. L.A. DeGiorgio et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus Nature Medicine 7 11 2001 1189-1193
26. S.A. Lipton P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders New England Journal of Medicine 330 9 1994 613-622
27. Harrison, M.J., Ravdin L., Volpe B., et al., Anti-NR2 antibody does not identify cognitive dysfunction in a general SLE population. in Seventh international congress on SLE and related conditions. 2004. New York, N.Y.
28. R. Omdal K. Brokstad K. Waterloo et al. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors European Journal of Neurology 12 2005 392-398
29. L.S. Teh D.A. Isenberg Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal Arthritis and Rheumatism 37 3 1994 307-315
30. E. Bonfa et al. Association between lupus psychosis and anti-ribosomal P protein antibodies New England Journal of Medicine 317 5 1987 265-271
31. A.G. Tzioufas et al. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: A large cohort of consecutive patients and patients with active central nervous system disease Annals of The Rheumatic Diseases 59 2 2000 99-104
32. F.C. Arnett et al. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations Arthritis and Rheumatism 39 11 1996 1833-1839
33. R. Gerli et al. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: Prospective evaluation in a large cohort of Italian patients Rheumatology (Oxford) 41 12 2002 1357-1366
34. E. Koren et al. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells Journal of Clinical Investigation 89 4 1992 1236-1241
35. K. Isshi S. Hirohata Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus Arthritis and Rheumatism 41 10 1998 1819-1827
36. J.G. Hanly Antiphospholipid syndrome: An overview Canadian Medical Association Journal 168 13 2003 1675-1682
37. P.E. Love S.A. Santoro Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance Annals of Internal Medicine 112 9 1990 682-698
38. S.D. Denburg et al. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus Journal of the International Neuropsychological Society 3 4 1997 377-386
39. J.G. Hanly et al. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus Arthritis and Rheumatism 42 4 1999 728-734
40. S. Menon et al. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus Arthritis and Rheumatism 42 4 1999 735-741
41. J. Chapman et al. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes Lupus 8 2 1999 127-133
42. S. Hirohata T. Miyamoto Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement Arthritis and Rheumatism 33 5 1990 644-649
43. S. Shiozawa et al. Interferon-alpha in lupus psychosis Arthritis and Rheumatism 35 4 1992 417-422
44. L.J. Jara et al. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus Clinical Rheumatology 17 2 1998 110-114
45. S. Hirohata K. Hayakawa Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus Arthritis and Rheumatism 42 12 1999 2729-2730
46. E. Trysberg H. Carlsten A. Tarkowski Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement Lupus 9 7 2000 498-503
47. R. Dellalibera-Joviliano et al. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus Journal of Rheumatology 30 3 2003 485-492
48. M.J. Rood et al. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes [see comments] Annals of The Rheumatic Diseases 58 2 1999 85-89
49. R. Gilad et al. Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus British Journal of Rheumatology 36 2 1997 190-193
50. A. Jonsen et al. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles Lupus 12 11 2003 846-850
51. H.R. Lijnen Plasmin and matrix metalloproteinases in vascular remodeling Journal of Thrombosis and Haemostasis 86 1 2001 324-333
52. A. Kalela et al. Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease Scandinavian Journal of Clinical and Laboratory Investigation 62 5 2002 337-342
53. R. Ross Atherosclerosis-an inflammatory disease New England Journal of Medicine 340 2 1999 115-126
54. M.A. Lee et al. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study Brain 122 Pt 2 1999 191-197
55. A. Creange et al. Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barre syndrome Neurology 53 8 1999 1683-1691
56. D. Ahrens et al. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis Arthritis and Rheumatism 39 9 1996 1576-1587
57. A. Faber-Elmann et al. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus Clinical and Experimental Immunology 127 2 2002 393-398
58. H. Ainiala et al. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities Arthritis and Rheumatism 50 3 2004 858-865
59. J. Montaner et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke Circulation 107 4 2003 598-603
60. N. Raskin In B.E. and Fauci AS K.J. et al. (eds.) Isselbacher Harrison's Principles Of Internal Medicine 1998 68-72
61. A. Fernandez-Nebro et al. Chronic or recurrent headache in patients with systemic lupus erythematosus: A case control study Lupus 8 2 1999 151-156
62. M. Amit et al. Headache in systemic lupus erythematosus and its relation to other disease manifestations Clinical and Experimental Rheumatology 17 4 1999 467-470
63. M.E. Lancman H. Mesropian R.J. Granillo Chronic aseptic meningitis in a patient with systemic lupus erythematosus The Canadian Journal of Neurological Sciences 16 3 1989 354-356
64. T. Kanekura J. Mizumoto M. Setoyama A case of lupus meningitis treated successfully with methylprednisolone pulse therapy Journal of Dermatology 20 9 1993 566-571
65. A. Escalante M.M. Stimmler Trimethoprim-sulfamethoxasole induced meningitis in systemic lupus erythematosus Journal of Rheumatology 19 5 1992 800-802
66. C. Codding I.N. Targoff G.A. McCarty Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus Arthritis and Rheumatism 34 10 1991 1340-1341
67. G.J. Gilbert H.W. Eichenbaum Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus Southern Medical Journal 82 4 1989 514-515
68. M. Bodani M.D. Kopelman A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus Lupus 12 12 2003 947-949
69. J. Wajed et al. Prevention of cardiovascular disease in systemic lupus erythematosus-proposed guidelines for risk factor management Rheumatology (Oxford) 43 1 2004 7-12
70. F.G. Jennekens L. Kater The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: A literature investigation Rheumatology (Oxford) 41 6 2002 605-618
71. J.W. Graham W. Jan MRI and the brain in systemic lupus erythematosus Lupus 12 12 2003 891-896
72. B. Kovacs et al. Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature Annals of Rheumatic Diseases 59 2 2000 120-124
73. R. Cervera et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature Medicine (Baltimore) 76 3 1997 203-212
74. A. Katzav J. Chapman Y. Shoenfeld CNS dysfunction in the antiphospholipid syndrome Lupus 12 12 2003 903-907
75. R. Omdal et al. Peripheral neuropathy in systemic lupus erythematosus-a longitudinal study Acta Neurologica Scandinavica 103 6 2001 386-391
76. R.H. Straub et al. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis Journal of Rheumatology 23 1 1996 87-92
77. F. Liote C.K. Osterland Autonomic neuropathy in systemic lupus erythematosus: Cardiovascular autonomic function assessment Annals of the Rheumatic Diseases 53 10 1994 671-674
78. S.L. Bloch et al. Brachial plexus neuropathy as the initial presentation of systemic lupus erythematosus Neurology 29 12 1979 1633-1634
79. V.M. Martinez-Taboada et al. Mononeuritis multiplex in systemic lupus erythematosus: Response to pulse intravenous cyclophosphamide Lupus 5 1 1996 74-76
80. H.W. van Laarhoven et al. Guillain-Barre syndrome as presenting feature in a patient with lupus nephritis, with complete resolution after cyclophosphamide treatment Nephrology, Dialysis, Transplantion 16 4 2001 840-842
81. M. Lewis T. Gibson Systemic lupus erythematous with recurrent Guillain-Barre-like syndrome treated with intravenous immunoglobulins Lupus 12 11 2003 857-859
82. E. Ben-Chetrit et al. Coexistence of systemic lupus erythematosus and myasthenia gravis: Two distinct populations of anti-DNA and anti-acetylcholine receptor antibodies Clinical and Experimental Rheumatology 8 1 1990 71-74
83. F.M. Grinlinton N.M. Lynch H.H. Hart A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy Arthritis and Rheumatism 34 7 1991 916-919
84. R.M. Carbotte S.D. Denburg J.A. Denburg Prevalence of cognitive impairment in systemic lupus erythematosus The Journal of Nervous and Mental Disease 174 6 1986 357-364
85. E.M. Wekking et al. Cognitive and emotional disturbances in systemic lupus erythematosus Psychotherapy and Psychosomatics 55 2-4 1991 126-131
86. K.S. Ginsburg et al. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus Arthritis and Rheumatics 35 7 1992 776-782
87. J.G. Hanly et al. Cognitive impairment in patients with systemic lupus erythematosus Journal of Rheumatology 19 4 1992 562-567
88. J.G. Hanly M.H. Liang Cognitive disorders in systemic lupus erythematosus. Epidemiologic and clinical issues Annals of The New York of Academy of Sciences 823 1997 60-68
89. E. Kozora et al. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease Arthritis and Rheumatism 39 12 1996 2035-2045
90. H. Ainiala et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus Neurology 57 3 2001 496-500
91. M.J. Prince et al. Is the cognitive function of older patients affected by antihypertensive treatment?. Results from 54 months of the medical research council's trial of hypertension in older adults British Medical Journal 312 7034 1996 801-805
92. L.P. Lowe et al. Type II diabetes and cognitive function. A population-based study of native Americans Diabetes Care 17 8 1994 891-896
93. J.G. Hanly et al. Clinical course of cognitive dysfunction in systemic lupus erythematosus Journal of Rheumatology 21 10 1994 1825-1831
94. J.G. Hanly K. Cassell J.D. Fisk Cognitive function in systemic lupus erythematosus: Results of a 5-year prospective study Arthritis and Rheumatism 40 8 1997 1542-1543
95. J.D. Fisk et al. Patterns of cognitive impairment in patients with systemic lupus erythematosus British Journal of Rheumatology 32 6 1993 458-462
96. E. Hay et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus Arthritis and Rheumatism 35 4 1992 411-416
97. R. Carbotte S. Denburg J. Denburg Cognitive dysfunction in systemic lupus erythematosus is independent of active disease Journal of Rheumatology 22 1995 863-867
98. S. Denburg R. Carbotte J. Denburg Psychological aspects of systemic lupus erythematosus: Cognitive function, mood, and self-report Journal of Rheumatology 24 1997 998-1003
99. E. Hay et al. A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus Annals of The Rheumatic Disease 53 5 1994 298-303
100. R. Monastero et al. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations Neurological Sciences 184 2001 33-39
101. S. Denburg R. Carbotte J. Denburg Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficits Journal of Clinical and Experimental Neuropsychology 9 4 1987 323-339
102. J. Fisk et al. Patterns of cognitive impairment in patients with systemic lupus erythematosus British Journal of Rheumatology 32 1993 458-462
103. S.D. Denburg R.M. Carbotte J.A. Denburg Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus Arthritis and Rheumatism 37 9 1994 1311-1320
104. T.A. Ahles et al. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the cancer and leukemia group B Journal of Clinical Oncology 16 5 1998 1954-1960
105. T.A. Ahles et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma Journal of Clinical Oncology 20 2 2002 485-493
106. E.M. Hay et al. A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus Annals of The Rheumatic Diseases 53 5 1994 298-303
107. S. Carlomagno et al. Cognitive impairment in systemic lupus erythematosus: A follow-up study Journal of Neurology 247 4 2000 273-279
108. K. Waterloo et al. Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study Rheumatology (Oxford) 41 4 2002 411-415
109. M. Lezak Neuropsychological Assessment 2 edn 1983 Oxford University Press New York
110. T.S.C. Pincus L.F. Callahan A self-report cognitive symptoms inventory to assess patients with rheumatic diseases: Results in eosinophilia-myalgia syndrome (EMS), fibromyalgia, rheumatoid arthritis (RA), and other rheumatic diseases (abstract) Arthritis and Rheumatism 39 supplement 9 1996 S261
111. M. Sanchez et al. Cognitive impairment (CI) in lupus is stable over time and may not be recognized by rheumatologists. Data from a multiethnic cohort Arthritis and Rheumatism 50 9 2004 S242
112. W.L. Sibbitt Jr R.R. Sibbitt W.M. Brooks Neuroimaging in neuropsychiatric systemic lupus erythematosus [see comments] Arthritis and Rheumatism 42 10 1999 2026-2038
113. W.J. McCune et al. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning Arthritis and Rheumatism 31 2 1988 159-166
114. M. Rovaris et al. Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study Journal of Neurology, Neurosurgery and Psychiatry 68 2 2000 170-177
115. W.L. Sibbitt Jr et al. Fluid attenuated inversion recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus Journal of Rheumatology 30 9 2003 1983-1989
116. J.G. Hanly Single photon emission computed tomography scanning in neuropsychiatric systemic lupus erythematosus [editorial; comment] Journal of Rheumatology 25 3 1998 401-403
117. J.C. Nossent et al. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus Arthritis and Rheumatism 34 11 1991 1397-1403
118. K. Oku et al. Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement Rheumatology (Oxford) 42 6 2003 773-777
119. A. Rubbert Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus [see comments] Arthritis and Rheumatism 36 9 1993 1253-1262
120. M.P. Rogers et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: A pilot study Lupus 1 4 1992 215-219
121. J.A. Kovacs The use of single photon emission computerized tomography in neuropsychiatric SLE: A pilot study [see comments] Journal of Rheumatology 22 7 1995 1247-1253
122. W.M. Brooks et al. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus Journal of Rheumatology 26 1 1999 81-85
123. A. Sabet et al. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus Stroke 29 11 1998 2254-2260
124. P.L. Peterson et al. Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus Lupus 12 12 2003 897-902
125. G.P. Bosma Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging [In Process Citation] Arthritis and Rheumatism 43 11 2000 2428-2436
126. G.P. Bosma et al. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging Arthritis and Rheumatism 43 1 2000 48-54
127. G.P. Bosma et al. Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus Arthritis and Rheumatism 46 10 2002 2665-2672
128. S.C. Steens et al. Selective gray matter damage in neuropsychiatric lupus Arthritis and Rheumatism 50 9 2004 2877-2881
129. T. Moritani et al. Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus Academic Radiology 8 8 2001 741-753
130. P. Small et al. Central nervous system involvement in SLE. Diagnostic profile and clinical features Arthritis and Rheumatism 20 3 1977 869-878
131. E. Trysberg et al. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement Arthritis and Rheumatism 48 10 2003 2881-2887
132. L. Barile C. Lavalle Transverse myelitis in systemic lupus erythematosus-the effect of IV pulse methylprednisolone and cyclophosphamide Journal of Rheumatology 19 3 1992 370-372
133. S. Eyanson et al. Methylprednisolone pulse therapy for nonrenal lupus erythematosus Annals of The Rheumatic Diseases 39 4 1980 377-380
134. V.F. Trevisani Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus (Cochrane review) [In Process Citation] Cochrane Database of Systematic Reviews 2000 3
135. V. Baca et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus Journal of Rheumatology 26 2 1999 432-439
136. F.K. Leung P.R. Fortin Intravenous cyclophosphamide and high dose corticosteroids improve MRI lesions in demyelinating syndrome in systemic lupus erythematosus Journal of Rheumatology 30 8 2003 1871-1873
137. D.T. Boumpas et al. Pulse cyclophosphamide for severe neuropsychiatric lupus Quantum Journal of Medicine 81 296 1991 975-984
138. C.M. Neuwelt et al. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus American Journal of Medicine 98 1 1995 32-41
139. P.C. Ramos et al. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus Clinical and Experimental Rheumatology 14 3 1996 295-299
140. C.C. Mok et al. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome Journal of Rheumatology 25 3 1998 467-473
141. G. Galindo-Rodriguez et al. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: An open trial American Journal of Medicine 106 1 1999 65-69
142. W.J. McCune et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus New England Journal of Medicine 318 22 1988 1423-1431
143. C.C. Mok C.S. Lau R.W. Wong Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: An open-label study American Journal of Medicine 115 1 2003 59-62
144. C. Gorman M. Leandro D. Isenberg Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus? Lupus 13 5 2004 312-316
145. K. Saito et al. Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement Lupus 12 10 2003 798-800
146. G. Sanna et al. Central nervous system involvement in the antiphospholipid (Hughes) syndrome Rheumatology (Oxford) 42 2 2003 200-213
147. M.A. Khamashta et al. The management of thrombosis in the antiphospholipid-antibody syndrome [see comments] New England Journal of Medicine 332 15 1995 993-997
148. M.A. Crowther et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome New England Journal of Medicine 349 12 2003 1133-1138
149. M.J. Harrison et al. Development of a unique and novel psycho-educational program for active systemic lupus erythematosus (SLE) patients with self-perceived cognitive difficulties Arthritis and Rheumatism 49 9 2003 S1685
150. M.J. Harrison et al. Preliminary results of a novel psycho-educational program designed for systemic lupus erythematosus (SLE) patients with self-perceived cognitive difficulties Arthritis and Rheumatism 49 supplement 9 2003 S1058
151. M.J. Harrison et al. MINDFULL: Mastering the intellectual navigation of daily functioning and undoing the limitations of lupus-a pilot study to improve quality of life in SLE Arthritis and Rheumatism 50 supplement 9 2004 S242
152. J.G. Hanly Neuropsychiatric lupus Current Rheumatology Reports 3 2001 205-212